The Office of the Additional Director, Medical Store Depot, CGHS, is conducting an assessment of local manufacturing capacity for specific medicines. Manufacturers and authorized importers are requested to provide information and documentation regarding 12 listed medicines, including Obinutuzumab and Rimegepant. Required submissions include CDSCO forms, registration certificates, GST details, and intellectual property documentation. Interested parties must submit the requested documents to the Medical Store Depot via email within 15 days. This initiative aims to identify potential suppliers to ensure the availability of these medicines for CGHS beneficiaries.

The Office of the Additional Director, Medical Store Depot, CGHS, is conducting an assessment of local manufacturing capacity for specific medicines. Manufacturers and authorized importers are requested to provide information and documentation regarding 12 listed medicines, including Obinutuzumab and Rimegepant. Required submissions include CDSCO forms, registration certificates, GST details, and intellectual property documentation. Interested parties must submit the requested documents to the Medical Store Depot via email within 15 days. This initiative aims to identify potential suppliers to ensure the availability of these medicines for CGHS beneficiaries.